Specifically, we observed in this region (including the genes IGF2, IGF2AS, INS, INS-IGF2, and MIR483) frequent cnLOH or LOH associated with CN loss in ACC (54% and 23% of cases, respectively) and CN gains in 25% of ACA. This evidence concerns the gene IGF2-AS and adrenal cortex carcinoma.